Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-005753
Filing Date
2025-08-07
Accepted
2025-08-07 16:02:03
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2025 sonoma_i10q-063025.htm   iXBRL 10-Q 540554
2 AMENDMENT NO. 3 TO MASTER SUPPLY AGREEMENT sonoma_ex1031.htm EX-10.31 8429
3 CERTIFICATION sonoma_ex3101.htm EX-31.1 8380
4 CERTIFICATION sonoma_ex3102.htm EX-31.2 8305
5 CERTIFICATION sonoma_ex3201.htm EX-32.1 4291
  Complete submission text file 0001683168-25-005753.txt   3592976

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE snoa-20250630.xsd EX-101.SCH 25952
7 XBRL CALCULATION FILE snoa-20250630_cal.xml EX-101.CAL 51385
8 XBRL DEFINITION FILE snoa-20250630_def.xml EX-101.DEF 87723
9 XBRL LABEL FILE snoa-20250630_lab.xml EX-101.LAB 284054
10 XBRL PRESENTATION FILE snoa-20250630_pre.xml EX-101.PRE 229056
62 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-063025_htm.xml XML 388599
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 251193770
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)